WelChol® and Insulin in Treating Patients With Type 2 Diabetes
NCT00151749
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Colesevelam hydrochloride
Sponsor
Daiichi Sankyo